Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

Fabien Grimaud,1 Guillaume Penaranda,2 Chloé Stavris,3 Frédérique Retornaz,3 Véronique Brunel,4 Sylvie Cailleres,4 Hervé Pegliasco,5 Jacques Le Treut,5 Vincent Grisoni,6 Emilie Coquet,1 Laurent Chiche,3 Amélie Rognon1 1Department of Pharmacy, Hôpital Européen, Marseille, France; 2Department of Biost...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Grimaud F, Penaranda G, Stavris C, Retornaz F, Brunel V, Cailleres S, Pegliasco H, Le Treut J, Grisoni V, Coquet E, Chiche L, Rognon A
Format: article
Langue:EN
Publié: Dove Medical Press 2021
Sujets:
immunotherapy
elderly
pd-1 inhibitor
pdl-1 inhibitor
safety
immune-related adverse events
solid tumours
prognostic biomarkers.
Therapeutics. Pharmacology
RM1-950
Accès en ligne:https://doaj.org/article/cf0fa7d1c6224b17bb4974e05a1f4225
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/cf0fa7d1c6224b17bb4974e05a1f4225

Documents similaires